Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols

References

• Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003;81(11):678-99
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992;256(5054):184-5
   PubMed Web of Science ®Google Scholar
• Pesek T, Reminick R, Nair M. Secrets of long life: cross-cultural explorations in sustainably enhancing vitality and promoting longevity via elders’ practice wisdom. Explore (NY) 2010;6(6):352-8
   PubMedGoogle Scholar
• Finnish Geriatric intervention study to prevent cognitive impairment and disability (FINGER). Available from: http://clinicaltrials.gov/ct2/show/NCT01041989
   Google Scholar
• Alzforum. Available from: www.alzforum.org/news/conference-coverage/healthy-lives-healthy-minds-it-really-true
   Google Scholar
• Martínez-González M, García-López M, Bes-Rastrollo M, et al. Mediterranean diet and the incidence of cardiovascular disease: a Spanish cohort. Nutr Metab Cardiovasc Dis 2011;21(4):237-44
   PubMed Web of Science ®Google Scholar
• Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92(5):1189-96
   PubMed Web of Science ®Google Scholar
• Tangney CC, Kwasny MJ, Li H, et al. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr 2011;93(3):601-7
   PubMed Web of Science ®Google Scholar
• Féart C, Samieri C, Allès B, Barberger-Gateau P. Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc Nutr Soc 2013;72(1):140-52
   PubMedGoogle Scholar
• Hamer M, McNaughton SA, Bates CJ, Mishra GD. Dietary patterns, assessed from a weighed food record, and survival among elderly participants from the United Kingdom. Eur J Clin Nutr 2010;64(8):853-61
   PubMed Web of Science ®Google Scholar
• Giacosa A, Barale R, Bavaresco L, et al. Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev 2013;22(1):90-5
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR. Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population. Climacteric 2013;16(Suppl 1):85-95
   PubMedGoogle Scholar
• Tyrovolas S, Panagiotakos DB. The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: a systematic review. Maturitas 2010;65(2):122-30
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009;64(2):67-79
   PubMedGoogle Scholar
• Bach-Faig A, Berry EM, Lairon D, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr 2011;14(12A):2274-84
   Google Scholar
• Pallauf K, Giller K, Huebbe P, Rimbach G. Nutrition and healthy ageing: calorie restriction or polyphenol-rich “MediterrAsian” diet? Oxid Med Cell Longev 2013;2013:707421
   PubMed Web of Science ®Google Scholar
• Stefani M, Rigacci S. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int J Mol Sci 2013;14(6):12411-57
   PubMed Web of Science ®Google Scholar
• Stefani M, Rigacci S. Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors 2014;40(5):482-93
   PubMed Web of Science ®Google Scholar
• Lourida I, Soni M, Thompson-Coon J, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 2013;24(4):479-89
   PubMed Web of Science ®Google Scholar
• Valls-Pedret C, Lamuela-Raventós RM, Medina-Remón A, et al. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alzheimers Dis 2012;29(4):773-8
   PubMed Web of Science ®Google Scholar
• Santoro A, Pini E, Scurti M, et al. Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project’s conceptual framework and design. Mech Ageing Dev 2014;136-137:3-13
   PubMed Web of Science ®Google Scholar
• Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature 2010;464(7288):529-35
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann NY Acad Sci 2010;1207:155-62
   PubMed Web of Science ®Google Scholar
• Martínez-Lapíscína EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 2013;17(6):544-52
   PubMedGoogle Scholar
• Jacomelli M, Pitozzi V, Zaid M, et al. Dietary extra-virgin olive oil rich in phenolic antioxidants and the aging process: long-term effects in the rat. J Nutr Biochem 2010;21(4):290-6
   PubMedGoogle Scholar
• Rigacci S, Guidotti V, Bucciantini M, et al. Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res 2011;8(8):841-52
   PubMedGoogle Scholar
• Diomede L, Rigacci S, Romeo M, et al. Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit. PLoS One 2013;8(3):e58893
   Google Scholar
• Luccarini I, Ed Dami T, Grossi C, et al. Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain. Neurosci Lett 2014;558:67-72
   PubMed Web of Science ®Google Scholar
• Grossi C, Rigacci S, Ambrosini S, et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLoS One 2013;8(8):e71702
   PubMed Web of Science ®Google Scholar
• Grossi C, Ed Dami T, Rigacci S, et al. Employing Alzheimer Disease animal models for translational research: focus on dietary components. Neurodegener Dis 2014;13(2-3):131-4
   PubMedGoogle Scholar
• Sindona G, Caruso A, Cozza A, et al. Anti-inflammatory effect of 3,4-DHPEA-EDA [2-(3,4 -hydroxyphenyl) ethyl (3S, 4E)-4-formyl-3-(2-oxoethyl)hex-4-enoate] on primary human vascular endothelial cells. Curr Med Chem 2012;19(23):4006-13
   PubMedGoogle Scholar
• Impellizzeri D, Esposito E, Mazzon E, et al. The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. Clin Nutr 2011;30(4):533-40
   PubMedGoogle Scholar
• Daccache A, Lion C, Sibille N, et al. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int 2011;58(6):700-7
   PubMedGoogle Scholar
• Rigacci S, Guidotti V, Bucciantini M, et al. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem 2010;21(8):726-35
   PubMedGoogle Scholar
• Abuznait AH, Qosa H, Busnena BA, et al. Olive-oil-derived oleocanthal enhances β-Amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s Disease: in vitro and in vivo studies. ACS Chem Neurosci 2013;4(6):973-82
   PubMed Web of Science ®Google Scholar
• Beauchamp GK, Keast RS, Morel D, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005;437(7055):45-6
   PubMed Web of Science ®Google Scholar
• Bioactivity of olive oils enriched with their own phenolic compounds (VOHF1). Available from: http://clinicaltrials.gov/ct2/show/NCT01347515
   Google Scholar
• de Bock M, Derraik JGB, Brennan CM, et al. Olive (Olea Europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight man: a randomized, placebo-controlled, crossover trial. PLoS One 2013;8(3):e57622
   PubMed Web of Science ®Google Scholar
• Serra A, Rubio L, Borras X, et al. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol Nutr Food Res 2012;56(3):486-96
   PubMedGoogle Scholar
• de Bock M, Thorstensen EB, Derraik JGB, et al. Human absorption and metabolism of oleuropein and hydroxythyrosol ingested as olive (Olea Europaea L.) leaf extract. Mol Nutr Food Res 2013;57:2079-85
   PubMed Web of Science ®Google Scholar
• Mourtzinos I, Salta F, Yannakopoulou K, et al. Encapsulation of olive leaf extract in beta-cyclodextrin. J Agric Food Chem 2007;55(20):8088-94
   PubMedGoogle Scholar
• Simini B. Serge Renaud: from French paradox to Cretan miracle. Lancet 2000;355(9197):48
   PubMedGoogle Scholar
• Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med 2014;174(7):1077-84
   PubMed Web of Science ®Google Scholar
• Pallàs M, Porquet D, Vicente A, Sanfeliu C. Resveratrol: new avenues for a natural compound in neuroprotection. Curr Pharm Des 2013;19(38):6726-31
   PubMed Web of Science ®Google Scholar
• Wang J, Bi W, Cheng A, et al. Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer’s disease-experimental approach and therapeutic implications. Front Aging Neurosci 2014;6:42
   PubMed Web of Science ®Google Scholar
• Lu C, Guo Y, Yan J, et al. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer’s disease. J Med Chem 2013;56(14):5843-59
   PubMed Web of Science ®Google Scholar
• Frozza RL, Bernardi A, Hoppe JB, et al. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules. Mol Neurobiol 2013;47(3):1066-80
   PubMed Web of Science ®Google Scholar
• Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health – A comprehensive review of human clinical trials. Mol Nutr Food Res 2011;55(8):1129-41
   PubMed Web of Science ®Google Scholar
• The cognitive and cerebral blood flow effects of resveratrol. Available from: http://clinicaltrials.gov/ct2/show/NCT01010009
   Google Scholar
• Resveratrol for improved performance in the elderly (RIPE). Available from: http://clinicaltrials.gov/ct2/show/NCT01126229
   Google Scholar
• Anton SD, Embry C, Marsiske M, et al. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp Gerontol 2014;24(57C):181-7
   Google Scholar
• Randomized trial of a nutritional supplement in alzheimer’s disease. Available from: http://clinicaltrials.gov/ct2/show/NCT00678431
   Google Scholar
• Pilot Study of the effects of resveratrol supplement in mild-to-moderate alzheimer’s disease. Available from: http://clinicaltrials.gov/ct2/show/NCT00743743
   Google Scholar
• Witte AV, Kerti L, Margulies DS, Floel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci 2014;34(23):7862-70
   PubMed Web of Science ®Google Scholar
• Resveratrol for Alzheimer’s Disease. Available from: http://clinicaltrials.gov/ct2/show/NCT01504854
   Google Scholar
• Effects of dietary interventions on the brain in mild cognitive impairment (MCI). Available from: http://clinicaltrials.gov/ct2/show/NCT01219244
   Google Scholar
• Ozawa M, Ninomiya T, Ohara T, et al. Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr 2013;97(5):1076-82
   PubMed Web of Science ®Google Scholar
• Dodge HH, Buracchio TJ, Fisher GG, et al. Trends in the prevalence of dementia in Japan. Int J Alzheimers Dis 2012;2012:956354
   PubMedGoogle Scholar
• Yamada T, Kadekaru H, Matsumoto S, et al. Prevalence of dementia in the older Japanese-Brazilian population. Psychiatry Clin Neurosci 2002;56(1):71-5
   PubMedGoogle Scholar
• Willcox DC, Scapagnini G, Willcox BJ. Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet. Mech Ageing Dev 2014;136-137:148-62
   PubMed Web of Science ®Google Scholar
• Ganguli M, Chandra V, Kamboh MI, et al. Apolipoprotein E polymorphism and Alzheimer disease-The Indo-US cross-national dementia study. Arch Neurol 2000;57(6):824-30
   PubMedGoogle Scholar
• Monroy A, Lithgow GJ, Alavez S. Curcumin and Neurodegenerative Diseases. Biofactors 2013;39(1):122-32
   PubMed Web of Science ®Google Scholar
• Rokka J, Snellman A, Zona C, et al. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. Bioorg Med Chem 2014;22(9):2753-62
   PubMedGoogle Scholar
• Lee WH, Loo CY, Bebawy M, et al. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 2013;11(4):338-78
   PubMed Web of Science ®Google Scholar
• Brondino N, Re S, Boldrini A, et al. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. ScientificWorldJournal 2014:2014;174282
   Google Scholar
• 18. Month study of curcumin. Available from: http://clinicaltrials.gov/ct2/show/NCT01383161
   Google Scholar
• Curcumin and yoga therapy for those at risk for alzheimer’s disease. Available from: http://clinicaltrials.gov/ct2/show/NCT01811381
   Google Scholar
• Prasad S, Tyagi AK, Aggarwal BB. Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice. Cancer Res. Treat 2014;46(1):2-18
   Google Scholar
• Tiwari SK, Agarwal S, Seth B, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano 2014;8(1):76-103
   PubMed Web of Science ®Google Scholar
• Cheng KK, Yeung CF, Ho SW, et al. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer’s disease Tg2576 mice. AAPS J 2013;15(2):324-36
   PubMed Web of Science ®Google Scholar
• Chen X, Zhi F, Jia X, et al. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharmacol 2013;65(6):807-16
   PubMedGoogle Scholar
• Mourtas S, Lazar AN, Markoutsa E, et al. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem 2014;80:175-83
   PubMed Web of Science ®Google Scholar
• Improved oral bioavailability of curcumin incorporated into micelles. Available from: http://clinicaltrials.gov/ct2/show/NCT01982734
   Google Scholar
• Oral bioavailability of curcumin from micronized powder and liquid micelles in healthy young women and men. Available from: http://clinicaltrials.gov/ct2/show/NCT01925287
   Google Scholar
• Weinreb O, Amit T, Mandel S, Youdim MB. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 2009;4(4):283-96
   PubMed Web of Science ®Google Scholar
• Lim HJ, Shim SB, Jee SW, et al. Green tea catechin leads to global improvement among Alzheimer’s disease-related phenotypes in NSE/hAPP-C105 Tg mice. J Nutr Biochem 2013;24(7):1302-13
   PubMed Web of Science ®Google Scholar
• Reznichenko L, Kalfon L, Amit T, et al. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. Neurodegener Dis 2010;7(4):219-31
   PubMedGoogle Scholar
• Noguchi-Shinohara M, Yuki S, Dohmoto C, et al. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS One 2014;9(5):e96013
   PubMed Web of Science ®Google Scholar
• Tan LC, Koh WP, Yuan JM, et al. Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese Health Study. Am J Epidemiol 2008;167(5):553-60
   PubMed Web of Science ®Google Scholar
• Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for Clinical Trials: more Pitfalls than Promises? Int J Mol Sci 2011;12(9):5592-603
   PubMed Web of Science ®Google Scholar
• Kristen AV, Lehrke S, Buss S, et al. Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clin Res Cardiol 2012;101(10):805-13
   PubMed Web of Science ®Google Scholar
• Sunphenon EGCg (Epigallocatechin-Gallate) in the early stage of alzheimer´s disease (SUN-AK). Available from: http://clinicaltrials.gov/ct2/show/NCT00951834
   Google Scholar
• Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: epigallocatechin Gallate as Therapeutic Tool. Available from: http://clinicaltrials.gov/ct2/show/NCT01699711
   Google Scholar
• Effects of EGCG (Epigallocatechin Gallate) in Huntington’s Disease (ETON-Study). Available from: http://clinicaltrials.gov/ct2/show/NCT01357681
   Google Scholar
• Efficacy and safety of green tea polyphenol in de novo parkinson’s disease Patients. Available from: http://clinicaltrials.gov/ct2/show/NCT00461942
   Google Scholar
• Mignet N, Seguin J, Chabot GG. Bioavailability of polyphenol liposomes: a challenge ahead. Pharmaceutics 2013;5(3):457-71
   PubMedGoogle Scholar
• Smith A, Giunta B, Bickford PC, et al. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. Int J Pharm 2010;389(1-2):207-12
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou X, Yu Q, et al. Epigallocatechin-3-gallate (EGCG)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide To Reduce Amyloid-β Aggregation and Cytotoxicity. ACS Appl. Mater Interfaces 2014;6(11):8475-87
   PubMed Web of Science ®Google Scholar
• Xie H, Wang JR, Yau LF, et al. Catechins and procyanidins of Ginkgo biloba show potent activities towards the inhibition of β-amyloid peptide aggregation and destabilization of preformed fibrils. Molecules 2014;19(4):5119-34
   PubMedGoogle Scholar
• Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimers disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012;11(10):851-9
   PubMed Web of Science ®Google Scholar
• Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer’s disease and vascular dementia: results from a randomised controlled trial. Pharmacopsychiatry 2012;45(2):41-6
   PubMed Web of Science ®Google Scholar
• Weinmann S, Roll S, Schwarzbach C, et al. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr 2010;17:10-14
   Google Scholar
• Ihl R. Gingko biloba extract EGb 761®: clinical data in dementia. Int Psychogeriatr 2012;24(Suppl 1):S35-40
   Google Scholar
• Kasper S. Clinical data in early intervention. Int Psychogeriatr 2012;24(Suppl 1):S41-5
   Google Scholar
• Martin SL, Hardy TM, Tollefsbol TO. Medicinal chemistry of the epigenetic diet and caloric restriction. Curr Med Chem 2013;20(32):4050-9
   PubMed Web of Science ®Google Scholar
• Peynshaert K, Manshian BB, Joris F, et al. Exploiting Intrinsic Nanoparticle Toxicity: the Pros and Cons of Nanoparticle-Induced Autophagy in Biomedical Research. Chem Rev 2014;114(15):7581-609
   PubMed Web of Science ®Google Scholar
• Zaman M, Ahmad E, Qadeer A, et al. Nanoparticles in relation to peptide and protein aggregation. Int J Nanomedicine 2014;9:899-912
   PubMed Web of Science ®Google Scholar
• Li W, Sperry JB, Crowe A, et al. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J Neurochem 2009;110(4):1339-51
   PubMed Web of Science ®Google Scholar
• Expo. Available from: www.expo2015.org/it
   Google Scholar
• Effects of dietary interventions on the brain in mild cognitive impairment (MCI). Available from: http://clinicaltrials.gov/ct2/show/NCT01219244
   Google Scholar
• Donepezil or EGb761 in Improving Neurocognitive function in patients who have previously undergone radiation therapy for primary brain tumor or brain metastases. Available from: http://clinicaltrials.gov/ct2/show/NCT00070161
   Google Scholar
• Comparison of the panax ginseng + associations to ginkgo biloba in the treatment of cognitive function disorders. Available from: http://clinicaltrials.gov/ct2/show/NCT01637168
   Google Scholar
• A Pilot study of curcumin and ginkgo for treating alzheimer’s disease. Available from: http://clinicaltrials.gov/ct2/show/NCT00164749
   Google Scholar
• Evaluating Whole Foods Supplementation on Cognition. Available from: http://clinicaltrials.gov/ct2/show/NCT01672359
   Google Scholar
• Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma. Available from: http://clinicaltrials.gov/ct2/show/NCT00113841
   Google Scholar
• Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine. Available from: http://clinicaltrials.gov/ct2/show/NCT00595582
   Google Scholar